Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections

Journal of Clinical Microbiology

Volumn 36, Issue 8, 1998, Pages 2301-2307

  Verkooyen, R P ^a   Willemse, D ^a   Hiep Van Casteren, S C A M ^b   Mousavi Joulandan, S A ^c   Snijder, R J ^b   Van Den Bosch, J M M ^b   Van Helden, H P T ^b   Peeters, M F ^d   Verbrugh, H A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

^d CPRLab   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; COMPLEMENT FIXATION TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0031903506     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.8.2301-2307.1998     Document Type: Article

References (51)

1. Aldous, M. B., J. T. Grayston, S. P. Wang, and H. M. Foy. 1992. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J. Infect. Dis. 166:646-649.
2. Bauwens, J. E., M. S. Gibbons, M. M. Hubbard, and W. E. Stamm. 1991. Chlamydia pneumoniae (strain TWAR) isolated from two symptom-free children during evaluation for possible sexual assault. J. Pediatr. 119:591-593.
3. Ben Yaakov, M., Z. Lazarovich, S. Beer, A. Levin, I. Shoham, and I. Boldur. 1994. Prevalence of Chlamydia pneumoniae antibodies in patients with acute respiratory infections in Israel. J. Clin. Pathol. 47:232-235.
4. Biberfeld, G., and E. Gronowicz. 1976. Mycoplasma pneumoniae is a polyclonal B-cell activator. Nature 261:238-239.
5. Boom, R., C. J. Sol, M. M. Salimans, C. L. Jansen, P. M. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
6. Brade, L., H. Brunnemann, M. Ernst, Y. Fu, O. Holst, P. Kosma, H. Naher, K. Persson, and H. Brade. 1994. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunol. Med. Microbiol. 8:27-41.
7. Brade, L., O. Holst, P. Kosma, Y. X. Zhang, H. Paulsen, R. Krausse, and H. Brade. 1990. Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide. Infect. Immun. 58:205-213.
8. Campbell, L. A., M. Perez Melgosa, D. J. Hamilton, C. C. Kuo, and J. T. Grayston. 1992. Detection of Chlamydia pneumoniae by polymerase chain reaction. J. Clin. Microbiol. 30:434-439.
9. Chirgwin, K., P. M. Roblin, M. Gelling, M. R. Hammerschlag, and J. Schachter. 1991. Infection with Chlamydia pneumoniae in Brooklyn. J. Infect. Dis. 163:757-761.
10. Chow, A. W., C. B. Hall, J. O. Klein, R. B. Kammer, R. D. Meyer, and J. S. Remmington. 1992. Guidelines for the evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clin. Infect. Dis. 15(Suppl. 1):S62-S88.
11. Cohen, B. H., W. C. J. Ball, S. Brashears, E. L. Diamond, P. Kreiss, D. A. Levy, H. A. Menkes, S. Permutt, and M. S. Tockman. 1977. Risk factors in chronic obstructive pulmonary disease (COPD). Am. J. Epidemiol. 105:223-232.
12. Cosentini, R., F. Blasi, R. Raccanelli, S. Rossi, C. Arosio, P. Tarsia, A. Randazzo, and L. Allegra. 1996. Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae. Respiration 63:61-65.
13. Ekman, M. R., M. Leinonen, H. Syrjala, E. Linnanmaki, P. Kujala, and P. Saikku. 1993. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur. J. Clin. Microbiol. Infect. Dis. 12:756-760.
14. Emre, U., P. M. Roblin, M. Gelling, W. Dumomay, M. Rao, M. R. Hammerschlag, and J. Schachter. 1994. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch. Pediatr. Adolesc. Med. 148:727-732.
15. Falck, G., J. Gnarpe, and H. Gnarpe. 1996. Persistent Chlamydia pneumoniae infection in a Swedish family. Scand. J. Infect. Dis. 28:271-273.
16. Falck, G., L. Heyman, J. Gnarpe, and H. Gnarpe. 1994. Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. Scand. J. Infect. Dis. 26:179-187.
17. Falguera, M., A. Nogues, and A. Ruiz-Gonzalez. 1996. Community-acquired Chlamydia pneumoniae pneumonia. Thorax 51:967.
18. Freidank, H. M., and D. Brauer. 1993. Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students. J. Infect. 27:89-93.
19. Gaydos, C. A., J. J. Eiden, D. Oldach, L. M. Mundy, P. Auwaerter, M. L. Warner, E. Vance, A. A. Burton, and T. C. Quinn. 1994. Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. Clin. Infect. Dis. 19:157-160.
20. Gaydos, C. A., P. M. Roblin, M. R. Hammerschlag, C. L. Hyman, J. J. Eiden, J. Schachter, and T. C. Quinn. 1994. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J. Clin. Microbiol. 32:903-905.
21. Grayston, J. T., M. B. Aldous, A. Easton, S. P. Wang, C. C. Kuo, L. A. Campbell, and J. Altman. 1993. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J. Infect. Dis. 168:1231-1235.
22. Grayston, J. T., C. C. Kuo, S. P. Wang, and J. Altman. 1986. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N. Engl. J. Med. 315:161-168.
23. Grayston, J. T., S. P. Wang, C. C. Kuo, and L. A. Campbell. 1989. Current knowledge on Chlamydia pneumoniae, strain TWAR. an important cause of pneumonia and other acute respiratory diseases. Eur. J. Clin. Microbiol. Infect. Dis. 8:191-202.
24. Higgings, M. W., J. B. Keller, J. R. Landis, T. H. Beaty, B. Burrows, D. Demets, J. E. Diem, I. T. T. Higgings, E. Lakatos, et al. 1984. Risk of chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 130:385.
25. Holst, O., L. Brade, P. Kosma, and H. Brade. 1991. Structure, serological specificity, and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia spp. J. Bacteriol. 173:1862-1866.
26. Hyman, C. L., M. H. Augenbraun, P. M. Roblin, J. Schachter, and M. R. Hammerschlag. 1991. Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR. J. Clin. Microbiol. 29:2082-2083.
27. Hyman, C. L., P. M. Roblin, C. A. Gaydos, T. C. Quinn, J. Schachter, and M. R. Hammerschlag. 1995. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin. Infect. Dis. 20:1174-1178.
28. Karvonen, M., J. Tuomilehto, J. Pitkaniemi, and P. Saikku. 1993. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987. Epidemiol. Infect. 110:349-360.
29. Kauppinen, M. T., and P. Saikku. 1995. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis and treatment. Clin. Infect. Dis. 21:S244-S255.
30. Kauppinen, M. T., P. Saikku, P. Kujala, E. Herva, and H. Syrjala. 1996. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 51:185-189.
31. Kern, D. G., M. A. Neill, and J. Schachter. 1993. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest 104:208-213.
32. Kleemola, M., P. Saikku, R. Visakorpi, S. P. Wang, and J. T. Grayston. 1988. Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J. Infect. Dis. 157:230-236.
33. Kwok, S. K., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339:237-238.
34. Marton, A., A. Karolyi, and A. Szalka. 1992. Prevalence of Chlamydia pneumoniae antibodies in Hungary. Eur. J. Clin. Microbiol. Infect. Dis. 11:139-142.
35. Moss, T. R., S. Darougar, R. M. Woodland, M. Nathan, R. J. Dines, and V. Cathrine. 1993. Antibodies to Chlamydia species in patients attending a genitourinary clinic and the impact of antibodies to C. pneumoniae and C. psittaci on the sensitivity and the specificity of C. trachomatis serology tests. Sex. Transm. Dis. 20:61-65.
36. Osser, S. and K. Persson. 1989. Immune response to genital chlamydial infection and influence of Chlamydia pneumoniae (TWAR) antibodies. Eur. J. Clin. Microbiol. Infect. Dis. 8:532-535.
37. Ozanne, G., and J. Lefebvre. 1992. Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections. Can. J. Microbiol. 38:1185-1189.
38. Pacheco, A., J. Gonzalez Sainz, C. Arocena, M. Rebollar, A. Antela, and A. Guerrero. 1991. Community acquired pneumonia caused by Chlamydia pneumoniae strain TWAR in chronic cardiopulmonary disease in the elderly. Respiration 58:316-320.
39. Saikku, P. 1982. Chlamydial serology. Scand. J. Infect. Dis. Suppl. 32:34-37.
40. Steinhoff, D., H. Lode, G. Ruckdeschel, B. Heidrich, A. Rolfs, F. J. Fehrenbach, H. Mauch, G. Hoffken, and J. Wagner. 1996. Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin. Infect. Dis. 22:958-964.
41. Sundelof, B., J. Gnarpe, H. Gnarpe, L. Grillner, and S. Darougar. 1993. Chlamydia pneumoniae in Swedish patients. Scand. J. Infect. Dis. 25:429-433.
42. Tjhie, H. T., J. H. Kock, J. J. Theunissen, E. Stolz, and D. M. MacLaren. 1994. Successful culture of Chlamydia pneumoniae in 2 asymptomatic patients. Ned. Tijdschr. Geneeskd. 138:1913-1916. (In Dutch.)
43. Van Renterghem, L., A. M. Van den Abeele, G. Claeys, and J. Plum. 1990. Prevalence of antibodies to Chlamydia pneumoniae in a pediatric hospital population in Belgium. Eur. J. Clin. Microbiol. Infect. Dis. 9:347-349.
44. Verkooyen, R. P., M. A. Hazenberg, G. H. Van Haaren, J. M. Van Den Bosch, R. J. Snijder, H. P. Van Helden, and H. A. Verbrugh. 1992. Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor. J. Clin. Microbiol. 30:1287-1290.
45. Verkooyen, R. P., S. A. Mousavi Joulandan, and H. A. Verbrugh. 1992. Effect of cell type, test organism and DEAE-dextran on the performance of tissue culture for Chlamydia pneumoniae, abstr. 541, p. 201. In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
46. Verkooyen, R. P., M. Sijmons, E. Fries, A. van Belkum, and H. A. Verbrugh. 1997. Widely used, commercially available Chlamydia pneumoniae antigen contaminated with mycoplasma. J. Med. Microbiol. 46:419-424.
47. Verkooyen, R. P., N. A. Van Lent, S. A. Mousavi Joulandan, R. J. Snijder, J. M. Van Den Bosch, H. P. Van Helden, and H. A. Verbrugh. 1997. Diagnosis of Chlamydia pneumoniae infection in chronic obstructive pulmonary disease patients by using microimmunofluorescence and ELISA. J. Med. Microbiol. 56:959-965.
48. Wang, J. H., Y. C. Liu, D. L. Cheng, M. Y. Yeng, Y. S. Chen, and B. C. Chen. 1993. Seroprevalence of Chlamydia pneumoniae in Taiwan. Scand. J. Infect. Dis. 25:565-568.
49. Wang, S. P., and J. T. Grayston. 1970. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am. J. Ophthalmol. 70:367-374.
50. Wang, S. P., J. T. Grayston, E. R. Alexander, and K. K. Holmes. 1975. Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J. Clin. Microbiol. 1:250-255.
51. Yamazaki, T., H. Nakada, N. Sakurai, C. C. Kuo, S. P. Wang, and J. T. Grayston. 1990. Transmission of Chlamydia pneumoniae in young children in a Japanese family. J. Infect. Dis. 162:1390-1392.